Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis

American Journal of Gastroenterology

Volumn 106, Issue 12, 2011, Pages 2133-2142

  Shaw, Souradet Y ^a   Blanchard, James F ^a   Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; METRONIDAZOLE;

ADULT; ARTICLE; CASE CONTROL STUDY; CROHN DISEASE; DATA BASE; DISEASE PREDISPOSITION; DRUG USE; ENTERITIS; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; ULCERATIVE COLITIS;

ADULT; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; CROHN DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG PRESCRIPTIONS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 82955251005     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.304     Document Type: Article

References (46)

1. Bernstein CN, Blanchard JF. Epidemiology of infl ammatory bowel disease. In: Cohen RD (ed). Clinical Gastroenterology: Infl ammatory Bowel Disease: Diagnosis and Therapeutics. Humana Press: Totowa, NJ, 2003 pp. 17-32.
2. Loftus EV Jr, Sandborn WJ. Epidemiology of infl ammatory bowel disease. Gastroenterol Clin N Am 2002; 31: 1-20. (Pubitemid 34733030)
3. Crohn's and Colitis Foundation of Canada. The Burden of Infl ammatory Bowel Disease (IBD) in Canada. Crohn's and Colitis Foundation of Canada: Toronto, 13 September 2008.
4. Podolsky DK. Infl ammatory bowel disease. NEJM 2005; 358: 1965-8.
5. Bernstein CN, Rawsthorne P, Cheang M et al. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 2006; 101: 993-1002. (Pubitemid 43725312)
6. Bernstein CN, Nayar G, Hamel A et al. A pursuit of animal borne infections in the mucosa of subjects with infl ammatory bowel disease and populationbased controls. J Clin Microbiol 2003; 41: 4986-90.
7. Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the modern epidemiology of infl ammatory bowel diseases. Gut 2008; 57: 1185-91.
8. Thompson NP, Driscoll R, Pounder RE et al. Genetics vs. environment in infl ammatory bowel disease: results of a British twin study. BMJ 1996; 312: 95-6. (Pubitemid 26015449)
9. Ott SJ, Musfeldt M, Wenderoth DF et al. Reduction in diversity of the colonic mucosa associated bacterial microfl ora in patients with active infl ammatory bowel disease. Gut 2004; 53: 685-93. (Pubitemid 38561447)
10. Sokol H, Lay C, Seksik P et al. Analysis of bacterial communities of IBD patients: what has it revealed? Infl amm Bowel Dis 2008; 14: 858-67. (Pubitemid 351898071)
11. Carradonna L, Amati L, Magrone T et al. Enteric bacteria, lipopolysaccharides and related cytokines in infl ammatory bowel disease: biological and clinical signifi cance. J Endotoxin Res 2000; 6: 205-14.
12. Manichanh C, Rigottier-Gois L, Bonnaud E et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2005; 55: 205-11. (Pubitemid 43117279)
13. Sokol H, Pigneur B, Watterlot t L et al. Faecalibacterium prausnitzii is an anti-infl ammatory commensal bacterium identifi ed by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci 2008; 105: 1671-8.
14. Sonnenberg A. Environmental infl uence in ulcerative colitis starts in early childhood. J Epidemiol Community Health 2008; 62: 992-4.
15. Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Sem Immunol 2007; 19: 70-83. (Pubitemid 46824070)
16. Dethlefsen L, Huse S, Sogin ML et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6: e280.
17. Jernberg C, Lofmark S, Edlund C et al. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007; 1: 56-66. (Pubitemid 46717132)
18. Card T, Logan RFA, Rodrigues LC et al. Antibiotic use and the development of Crohn's disease. Gut 2004; 53: 246-50. (Pubitemid 38125513)
19. Hildebrand H, Malmborg P, Askling J et al. Early-life exposures associated with antibiotic use and risk of subsequent Crohn's disease. Scand J Gastroenterol 2008; 43: 961-6.
20. Gilat T, Hacohen D, Lilos P et al. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987; 22: 1009-24. (Pubitemid 17152843)
21. Wurzelmann JI, Lyles CM, Sandler RS. Childhood infections and the risk of infl ammatory bowel disease. Dig Dis Sci 1994; 39: 555-60. (Pubitemid 24137343)
22. Watson DE, Katz A, Reid RJ et al. Family physician workloads and access to care in Winnipeg: 1991 to 2001. CMAJ 2004; 171: 339-42. (Pubitemid 39127986)
23. WHO. WHO's Collaborating Centre for Drug Statistics Methodology: ATC Classifi cation Index with DDDs and Guidelines for ATC Classifi cation and DDD Assignment. Norwegian Institute of Public Health: Oslo, Norway, 1999.
24. Metge CJ, Blanchard JF, Peterson S et al. Use of pharmaceuticals by infl ammatory bowel disease patients: a population-based study. Am J Gastroenterol 2001; 96: 3348-55. (Pubitemid 34016659)
25. Bernstein CN, Blanchard JF, Rawsthorne P et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a populationbased study. Am J Epidemiol 1999; 149: 916-24. (Pubitemid 29230706)
26. Brownell M, De Coster C, Penfold R et al. Manitoba Child Health Atlas Update. Manitoba Centre for Health Policy: Winnipeg, MB, 2008.
27. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the fi rst year of life and pediatric infl ammatory bowel disease. Am J Gastroenterol 2010; In press.
28. Long JS, Freese J. Regression Models for Categorical Dependent Variables Using Stata. StataCorp: College Station, TX, 2006.
29. Fanaro S, Chierici R, Guerrini P et al. Intestinal microfl ora in early infancy: composition and development. Acta Paediatr 2003; 441: 48-55. (Pubitemid 37239252)
30. Molodecky NA, Kaplan GG. Environmental risk factors for infl ammatory bowel disease. Gastroenterol Hepatol (NY) 2010; 6: 339-46.
31. Kozyrskyj A, Raymond C, Dahl M et al (ed). Eff ects of Manitoba Pharmacare Formulary Policy on Utilization of Prescription Medications. Manitoba Centre for Health Policy: Winnipeg, Canada, 2009.
32. Crohn B, Ginzburg L, Oppenheimer G. Regional ileitis, a pathological and clinical entity. JAMA 1932; 99: 1323-9.
33. Chiodini RJ. Historical overview and current approaches in determining a mycobacterial etiology in Crohn's disease. In: Mulder CJJ, Tytgat GNJ (eds). Is Crohn's Disease a Mycobacterial Disease. Kluwer Academic Publishers: Dordrecht, The Netherlands, 1992.
34. Baron JH. Infl ammatory bowel disease up to 1932. Mount Sinai J Med 2000; 67: 174-89.
35. Dalziel TK. Chronic interstitial enteritis. Br Med J 1913; 2: 1068-70.
36. Moschcowitz E, Wilensky A. Non-specifi c granulomata of the intestine. Am J Med Sci 1923; 166: 48-66.
37. Moschcowitz E, Wilensky A. Nonspecifi c granulomata of the small intestine. Am J Med Sci 1927; 173: 374-80.
38. Wilks S. Morbid appearances in the intestines of Miss Bankes. Medical Times Gazette 1859; 40: 264-5.
39. Wilks S, Moxon W. Lectures on Pathological Anatomy. Churchill: London, 1875.
40. Allchin WH. A case of extensive ulceration of the colon. Trans Patholog Soc London 1885; 36: 199-202.
41. Hale-White W. On simple ulcerative colitis and other intestinal ulcers. Guy's Hospital Rep 1888; 45: 131.
42. Ogle JW. Effervescing bismuth water. Br Med J 1864; 1: 249-50.
43. Marshall BDL. Commentary: Helicobacter as the " environmental factor " in Susser and Stein's cohort theory of peptic ulcer disease. Int J Epidemiol 2002; 31: 21-2.
44. Bach JF. The eff ect of infections on susceptibility to autoimmune and allergic diseases. NEJM 2002; 347: 911-9.
45. Kozyrskyj AL, Carrie AG, Mazowita GB et al. Decrease in antibiotic use among children in the 1990s: not all antibiotics, not all children. CMAJ 2004; 171: 133-8. (Pubitemid 39013263)
46. Freeman CD, Klutman NE, Lamp KC. Metronidazole. A therapeutic review and update. Drugs 1997; 54: 679-708. (Pubitemid 27480240)